Trade Janux Therapeutics, Inc. - JANX CFD

Trading Conditions

• Type: CFD
• Spread: 0.11
• Long position overnight funding adjustment: -0.02157%
• Short position overnight funding adjustment: -0.00065%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 0.1
• Margin: 50.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 14.45
• Open: 14.31
• 1-Year Change: -46.46%
• Day's Range: 14.31 - 14.8

Trade Janux Therapeutics, Inc. - JANX CFD

What is Janux Therapeutics, Inc. (JANX)?

Janux Therapeutics, Inc. is a biotechnology company focused on the development of novel immunotherapies for cancer treatment. The company specializes in creating therapies that modulate the immune system to target and eliminate cancer cells. Its research and development efforts are centered on leveraging the body's natural immune responses to improve patient outcomes. Janux Therapeutics employs advanced scientific techniques to identify and develop drug candidates aimed at enhancing immune system activity against tumors. The company collaborates with academic institutions and industry partners to advance its pipeline of therapeutic candidates through preclinical and clinical stages. Janux Therapeutics operates within the broader biopharmaceutical sector, contributing to the innovation of cancer immunotherapy approaches. Its strategic focus includes addressing unmet medical needs in oncology by developing treatments that can potentially offer improved efficacy and safety profiles compared to existing therapies. The company’s activities encompass research, development, and potential commercialization of immune-based cancer therapies.

Janux Therapeutics, Inc. Stock Price Today: Live Overview

The price today is shaped by intraday fluctuations, as Janux Therapeutics, Inc. is currently at $14.76. The session has seen prices fluctuate between $14.01 and $14.81, showing a daily change of +2.4931%.

FAQ: Janux Therapeutics, Inc. (JANX)

What is the current price of JANX stock?

Trading currently values the stock at $14.76.

Does JANX pay dividends?

Janux Therapeutics, Inc. does not pay dividends.

Does JANX have a formal corporate presence or regional headquarters in the UAE?

Janux Therapeutics does not have an official presence or subsidiary in the UAE and operates through partnerships.

What is JANX best known for?

The company is most famous for developing immuno-oncology therapies.

What assets are typically shown together with JANX?

Commonly shown alongside JANX: AES, Sonova Holding, MasterCraft Boat Holdings Inc